☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Negative
Lundbeck Halts P-II Study of Lu AF11167 in Patients with Negative Symptoms of Schizophrenia
August 6, 2020
Lilly Reports Negative Results of Solanezumab in P-III EXPEDITION Studies in Patients with Alzheimer Disease
December 6, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.